Home2019-11-28T19:04:20-05:00

CONVERGING ON ENGINEERED SOLUTIONS FOR REGENERATIVE MEDICINE

Medicine by Design harnesses the extraordinary expertise at the University of Toronto and its affiliated hospitals to undertake transformative research in regenerative medicine and cell therapy, power Toronto’s bioscience sector and strengthen Canada as a global leader in the field.

LEARN MORE

Events

SEE ALL EVENTS

Latest News

Researchers delay onset of amyotrophic lateral sclerosis (ALS) in laboratory models

April 22nd, 2020|

A team of researchers led by scientists at the University of Toronto has delayed the onset of amyotrophic lateral sclerosis (ALS) in mice. They are cautiously optimistic that this research, which was funded in part by a Medicine by Design 2018 New Ideas Award, combined with other clinical advances, points to a potential treatment for ALS in humans.

SEE ALL NEWS POSTS

Opportunities

Learn more about our award programs, job openings, and learning and knowledge mobilization opportunities.

SEE ALL OPPORTUNITIES

Medicine By Design By The Numbers

Toronto skyline icon

A Top Global Research University in the World's Most Diverse City

9 World-Class

Partner Hospitals, Including:

UHN, Mount Sinai, & Sick Kids Hospitals logos
Extended hand holding coins icon

$114-million grant over seven years

Two arrows circling each other icon

Collaborative Team Projects Advancing 8 Disease Areas and Enabling Technologies

140+

Regenerative Medicine Researchers

300+

Graduate Students and Post-Doctoral Fellows

A Vibrant Life Sciences Ecosystem Located in Canada's Urban Innovation Hub

Microscope icon

Sign Up To Receive Medicine By Design Updates

SUBSCRIBE